136 related articles for article (PubMed ID: 16303170)
1. Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor.
Tu Z; Gui L; Wang J; Li X; Sun P; Wei L
Gynecol Oncol; 2006 May; 101(2):274-9. PubMed ID: 16303170
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of [12Asp]K-ras4B on transcriptional activity of estrogen receptor in endometrial carcinoma HEC-1A cell lines].
Gui LM; Wei LH; Xu MX; Wang JL; Zhong YC; Li XP; Tu Z; Sun PM; Ma DL
Zhonghua Fu Chan Ke Za Zhi; 2004 Jan; 39(1):30-4. PubMed ID: 14989985
[TBL] [Abstract][Full Text] [Related]
3. [Carcinogenesis and its mechanism of mutant-type[12Asp]K-ras4B gene].
Gui LM; Wei LH; Zhang YM; Wang JL; Wang Y; Chen Y; Ma DL
Ai Zheng; 2002 Jan; 21(1):33-8. PubMed ID: 12500394
[TBL] [Abstract][Full Text] [Related]
4. Requirement of estrogen receptor expression and function for [12Val] K-Ras-mediated NIH3T3 cell transformation.
Kato K; Sakamoto T; Wake N
Oncology; 1998 Dec; 55 Suppl 1():45-52. PubMed ID: 9852401
[TBL] [Abstract][Full Text] [Related]
5. Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway.
Kato K; Horiuchi S; Takahashi A; Ueoka Y; Arima T; Matsuda T; Kato H; Nishida Ji J; Nakabeppu Y; Wake N
J Biol Chem; 2002 Mar; 277(13):11217-24. PubMed ID: 11781307
[TBL] [Abstract][Full Text] [Related]
6. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression of estrogen receptor-related receptor alpha can stimulate estrogen receptor negative endometrial cancer cell proliferation].
Sun PM; Wei LH; Gao M; Wang JL; Zhao LJ; Wang DP; Zhang JX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):408-11. PubMed ID: 17697604
[TBL] [Abstract][Full Text] [Related]
8. Contribution of enhanced transcriptional activation by ER to [12Val] K-Ras mediated NIH3T3 cell transformation.
Kato K; Ueoka Y; Kato K; Hachiya T; Nishida J; Wake N
Oncogene; 1997 Dec; 15(25):3037-46. PubMed ID: 9444952
[TBL] [Abstract][Full Text] [Related]
9. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.
Muratcioglu S; Aydin C; Odabasi E; Ozdemir ES; Firat-Karalar EN; Jang H; Tsai CJ; Nussinov R; Kavakli IH; Gursoy A; Keskin O
J Mol Biol; 2020 Feb; 432(4):1199-1215. PubMed ID: 31931009
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
[TBL] [Abstract][Full Text] [Related]
13. Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation.
Wu SY; Lan SH; Cheng DE; Chen WK; Shen CH; Lee YR; Zuchini R; Liu HS
Neoplasia; 2011 Dec; 13(12):1171-82. PubMed ID: 22241963
[TBL] [Abstract][Full Text] [Related]
14. An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.
Sun PM; Gao M; Wei LH; Mustea A; Wang JL; Könsgen D; Lichtenegger W; Sehouli J
Int J Gynecol Cancer; 2006; 16 Suppl 2():564-8. PubMed ID: 17010074
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
Kaplan JB
Oncol Res; 1994; 6(12):611-5. PubMed ID: 7787254
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary study of membrane estrogen receptor expression in endometrial carcinoma cells].
Wang ZQ; Wang JL; Wei LH; Zhao D; Gao M; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):471-5. PubMed ID: 17083814
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
[TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
19. [Effect of GPER on the activation of PI3K/Akt induced by 17β-estradiol in endometrial carcinoma cells].
Zhang YC; Guo RX; Ge X; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):292-6. PubMed ID: 22781117
[TBL] [Abstract][Full Text] [Related]
20. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
